APTO-500

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameAPTO-500

Drug Alias Namematernal embryonic leucine zipper kinase inhibitors (Lorus)maternal embryonic leucine zipper kinase inhibitors (Aptose)LOR-500APTO-500LOR-558 +[6]

ClassificationSmall molecules

Mechanisms of ActionMaternal embryonic leucine zipper kinase inhibitorsAnticancer protein kinase inhibitors

TargetsMaternal embryonic leucine zipper kinase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAptose Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAptose Biosciences Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A